Latest news
YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 12:00:00 GMTKeratoconus Study Ranks Molecules for Future Corneal Therapy Research - Stock TitanStock Titan · Tue, 04 Aug 2026 12:00:00 GMTYD Bio Limited Revenue Breakdown – BOATS:YDESW - TradingViewTradingView · Sat, 01 Aug 2026 15:39:49 GMTYD Bio Warrants (YDESW) Hover at $0.25 as Flat Session Points to Indecision - PCR Mean Reversion - dars.gov.etdars.gov.et · Sat, 01 Aug 2026 02:45:35 GMTYD Bio Warrants (YDESW) Hover at $0.25 as Flat Session Points to Indecision - IV Rank - dars.gov.etdars.gov.et · Sat, 01 Aug 2026 02:45:27 GMTYD Bio Launches Cross-Border Cancer Testing Pilot in Canada - Clinical Lab ProductsClinical Lab Products · Fri, 31 Jul 2026 19:30:18 GMTPrice to earnings forward of YD Bio Limited – NASDAQ:YDES - TradingViewTradingView · Thu, 30 Jul 2026 18:48:34 GMTYD Bio Ord Shs (YDES) Financial Health: Profitability & Balance Sheet Analysis - TradingKeyTradingKey · Tue, 28 Jul 2026 09:49:03 GMT